Loading…
Based on limited metadata, the FDA issued a Warning Letter to B. Jain Pharmaceuticals Private Limited, a pharmaceutical drug manufacturer, on March 21, 2019. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning pertains to drug products under FDA jurisdiction, though the specific issuing office and violation count are not documented in this metadata summary.